Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C. Widemann, Frank M. Balis, Jean B. Belasco et al.|Neuro-Oncology|2014Cited by 114
Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid TumorsR. Bagatell, Lia Gore, Cynthia E. Herzog et al.|Clinical Cancer Research|2010Cited by 48